Skip to main content

$0.030 (0%)

High

$0.03

Low

$0.03

Trades

25

Turnover

$28,362

Volume

960,646
30 June 2023 at 4:10pm
Register to track LBT and receive email alerts.
Subject
LBT Ann: Appendix 4G

LBT Ann: Corporate Governance Statement

LBT Ann: Annual Report to shareholders

LBT Ann: Initial Director's Interest Notice

LBT Ann: Company Presentation Thermo Fisher Appointed US Distributor

LBT Ann: Appointment of Laboratory Leader to the Board

LBT Ann: CCS Appoints Thermo Fisher as Exclusive US APAS Distributor

LBT Ann: Investor Webinar Presentation

LBT Ann: Appendix 4E and Annual Financial Statements

LBT Ann: Leading Microbiology Journal Publishes APAS Clinical Data

LBT Ann: Notification of cessation of securities - LBT

LBT Ann: Quarterly Activities/Appendix 4C Cash Flow Report

LBT Ann: APAS Independence Scientific Data Presented at ECCMID

LBT Ann: Proposed issue of securities - LBT

LBT Ann: Director Appointment/Resignation

LBT Ann: Market Update - US Commercial Progress

LBT Ann: Final Director's Interest Notice

LBT Ann: Non-Executive Director Retirement

LBT Ann: APAS Independence Sales to Health Services Laboratory, UK

LBT Ann: Change of Registered Office and Principal Place of Business

LBT Ann: Appendix 4C - quarterly

LBT Ann: Lapse of Unlisted Options

LBT Ann: Market Update - Distributors & Sales Activities

LBT Ann: Proposed issue of Securities - LBT

LBT Ann: Directors Purchase of Shares

LBT Ann: CEO Presentation - ShareCafe Webinar

LBT Ann: LBT Receives $0.83 Million R&D Tax Incentive

LBT Ann: Half Yearly Report and Accounts

LBT Ann: Market Update - Board Renewal Process

LBT Ann: Appendix 4C - quarterly

LBT Ann: Change of Director's Interest Notice

LBT Ann: Appendix 3G

LBT Ann: Cleansing Notice - Notice Under Section 708A

LBT Ann: Appendix 3G

LBT Ann: Appendix 2A

LBT Ann: Proposed issue of Securities - LBT

LBT Ann: Market Update - EU Commercial Activities

LBT Ann: Results of Meeting

LBT Ann: CEO Presentation - AGM 2020

LBT Ann: Chairman's Address to Shareholders

LBT Ann: Updated Requirements for Annual General Meeting

LBT Ann: Presentation at Australia Biotech Invest & Partnering 2020

LBT Ann: Appendix 4C - quarterly

LBT Ann: Timing of Quarterly Results & Investor Call

LBT Ann: Notice of Annual General Meeting/Proxy Form

Register to track LBT and receive email alerts.

Similar Companies

AT1
COH
CSX
CYC
EMV
IBX
IPD
MX1
RSH
SOM